- Advanced Human Imaging (AHI) finalises listing on the Nasdaq and completes a US$12 million (A$16.9 million) capital raising as part of its operations during the December quarter
- The company says the integration of its CompleteScan technology into the Nexus-Vita application is progressing with a US$100,000 (A$142,000) invoice issued for work completed to date
- Adjusted cash expenditure for the quarter was $1.8 million which the company says represents a 12 per cent reduction in spend from the previous year
- Chairman and CEO Vlado Bosanac says listing on the Nasdaq is a key step for enabling the company’s growth strategy
- Shares have been down 2 per cent at 49.5 cents
Advanced Human Imaging (AHI) has finalised its listing on the Nasdaq and completed a US$12 million (A$16.9 million) capital raising as part of its operations during the December quarter.
The company said the integration of its Complete Scan technology into the Nexus-Vita application is progressing with a US$100,000 (A$142,000) invoice issued for work completed to date.
However, Tinjoy’s The Health Cube application in China has reportedly been muted by the Chinese government’s zero-covid policy. According to AHI, Tinjoy’s efforts to increase the uptake in new daily active users will take longer than anticipated.
Adjusted cash expenditure for the quarter was $1.8 million, which the company said represents a 12 per cent reduction in spend from the previous year.
During this quarter the company received a $890,000 research and development rebate which is the largest in AHI’s history.
Chairman and CEO Vlado Bosanac said listing on the Nasdaq is a key step for enabling the company’s growth strategy.
“With closing of our Nasdaq initial public offering, we have a strong cash balance that we expect to further bolster as we near our revenue goals via our near-term partner releases,” he said.
Shares were down 2 per cent trading at 49.5 cents at 3.48 pm AEDT.